Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine.
about
1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues-Model Compounds Targeting Oxidative StressWhat is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendationsEffects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study.Extracellular matrix molecules: potential targets in pharmacotherapy.Exforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact.Effects of dihydropyridine calcium channel blockers on oxidized low-density lipoprotein induced proliferation and oxidative stress of vascular smooth muscle cells.Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS studyDifferential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen speciesPharmacological basis of different targets for the treatment of atherosclerosis.Differential regulation of Akt, caspases and MAP kinases underlies smooth muscle cell apoptosis during aortic remodelling in SHR treated with amlodipine.Optimal vascular protection: a case for combination antihypertensive therapy.Influence of serum cholesterol on atherogenesis and intimal hyperplasia after angioplasty: inhibition by amlodipine.Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies.Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination.Disrupting calcium channel expression to lower blood pressure: new targeting of a well-known channelAmlodipine attenuates oxidative stress in the heart and blood of high-cholesterol diet rabbits.Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives.Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survival.Single-pill combination of amlodipine and valsartan in the management of hypertension.Amlodipine increased endothelial nitric oxide and decreased nitroxidative stress disproportionately to blood pressure changes.Role of dihydropyridinic calcium channel blockers in the management of hypertension.Thiazide-like/calcium channel blocker agents: a major combination for hypertension management.Combination therapy in hypertension: what are the best options according to clinical pharmacology principles and controlled clinical trial evidence?Cav1.2, cell proliferation, and new target in atherosclerosis.Hypercholesterolemia and Hypertension: Two Sides of the Same Coin.Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine.Perspectives and challenges of antioxidant therapy for atrial fibrillation.Hyperoxaluria-induced tubular ischemia: the effects of verapamil on the antioxidant capacity of the affected kidneys.Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and Tolerability.A study of the association with blood pressure difference causing body temperature ≥37·5°C and hypertension in department of primary care.Is amlodipine more cardioprotective than other antihypertensive drug classes?Serum and gene expression profile of tumor necrosis factor-alpha and interleukin-6 in hypertensive diabetic patients: effect of amlodipine administration.Probable amlodipine-induced angioedema.Single-dose, randomized, crossover bioequivalence study of amlodipine maleate versus amlodipine besylate in healthy volunteers.Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.Treatment with triple combination of atorvastatin, perindopril, and amlodipine in patients with stable coronary artery disease: A subgroup analysis from the PAPA-CAD study.Effect of N-(p-coumaroyl)serotonin and N-feruloylserotonin, major anti-atherogenic polyphenols in safflower seed, on vasodilation, proliferation and migration of vascular smooth muscle cells.Amlodipine-induced angioedema: An unusual complication of a common medication.
P2860
Q26765819-95811518-D116-4EB9-ABD7-926953637286Q26864349-4240373D-DBE6-4F84-82BC-9B5E8B64FC09Q33690702-150BB5B1-D811-4BF2-AE6D-EE2F1408186CQ33694487-E214CD0B-048E-4275-9C29-175CFB24397EQ33973864-023190EF-9323-4CD4-B689-D21153464C70Q34210911-9D3C9C94-5A85-4850-962D-A20FEE159199Q34995916-14D84314-B1C3-4CA3-BBDC-7CA94A3C004DQ36276106-9CF27CB8-4E2B-4155-9A3D-8D78E4DF68C8Q36346487-049B5E54-1BB2-420A-9D02-3EFB75AC2CACQ36358107-3872F353-9117-4396-9032-376F39CF4F09Q36366297-6167338F-7CC3-46F0-8F4D-1F6F65B0B8D0Q36519863-96D234ED-61A5-4E6C-9C1E-F4C962FEE72AQ36686034-6C1BC3C1-553F-4F42-AC3E-E3FC603DC645Q36863534-49D1DC28-F919-45EB-8504-CFE59DAD3673Q36975796-7C15091D-1DAE-41EE-9633-4AD9D65DEACCQ37029616-EC6BBA22-7A2E-47B5-9C6F-AD70F570B92FQ37041493-BC0FCD99-610D-4754-8F52-8534403D9994Q37202140-FF7C0FB1-D05F-4C0C-8099-9CDF3E4090F9Q37281446-15F31807-D3A2-44EF-BA42-EB60CE8B25A0Q37552939-13A89829-43BC-4A9D-ABA1-5A6D7BCB6522Q37561135-975B1D2F-4234-4BA6-BA99-3FBDDBC86BABQ38069195-F50DEDE6-EE8D-4B8A-9871-94F80A5A8441Q38243976-7FC8EE5B-F96D-41A8-B41D-D70CF532AE4FQ38409909-73031128-84A9-4533-B28D-72691125E3B1Q38456978-816C8D1C-2588-4B42-BB96-8BA1EF2403B6Q38524257-87A4ABBA-6655-4FCF-97A5-471EDF76341CQ38852188-6FEEC8D1-AE8A-4D9D-8C3A-D5E26D1D74DFQ39024113-55C90FE1-F577-4E24-BDD6-FFF2FE09F5B1Q39698736-FE93D2FD-3377-42E3-AE9D-DAE21478D106Q39823023-51EA5580-E831-46D5-BE20-5895E5F3D4FAQ40246395-E6D8F575-F00E-41DD-B6C1-5B824C9338FEQ42582332-6B1F432E-3B9B-4DFA-A1E2-391F09853945Q43105940-7775D694-5E3F-401C-BCCC-4876B1C102B9Q46082214-47EFCCD4-EFDF-4445-901E-45F6967618C2Q46866899-3143C48E-4E21-48C9-89E4-CABECA899655Q51244807-F5724E9B-2777-4255-BE15-A246F1A6FA61Q52647190-2DDD38A5-8D97-4CCB-BD73-5553410276BBQ54584352-1D01E5F6-86F3-4FC9-966F-C385F7FA022AQ55517288-7E77B8BE-4F1C-4A56-A46A-CB8EDA8B6792
P2860
Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Novel vascular biology of thir ...... cillary actions of amlodipine.
@ast
Novel vascular biology of thir ...... cillary actions of amlodipine.
@en
type
label
Novel vascular biology of thir ...... cillary actions of amlodipine.
@ast
Novel vascular biology of thir ...... cillary actions of amlodipine.
@en
prefLabel
Novel vascular biology of thir ...... cillary actions of amlodipine.
@ast
Novel vascular biology of thir ...... cillary actions of amlodipine.
@en
P2093
P1476
Novel vascular biology of thir ...... cillary actions of amlodipine.
@en
P2093
P304
P356
10.1161/01.ATV.0000097770.66965.2A
P407
P577
2003-09-25T00:00:00Z